Showing results (31-40 of 233) with videos related to
Sort By:
Pageof 24
Expert Review of Anti-Infective Therapy|December 5, 2008
Measuring the severity of Clostridium difficile infection: implications for management and drug developmentJaime Belmares, Dale N Gerding, Glenn Tillotson, et al.Antimicrobial Agents and Chemotherapy|August 17, 2011
Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infectionEllie J C Goldstein, Diane M Citron, Pamela Sears, et al.Anaerobe|September 10, 2009
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007Adam K Cheknis, Susan P Sambol, David M Davidson, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2020
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor OutcomesStuart Johnson, Diane M Citron, Dale N Gerding, et al.Open Forum Infectious Diseases|March 4, 2015
Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard TherapiesMelinda M Soriano, Larry H Danziger, Dale N Gerding, et al.Journal of Medical Microbiology|August 18, 2004
Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospitalBarbara Geric, Maja Rupnik, Dale N Gerding, et al.Journal of Clinical Microbiology|November 8, 2003
Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxinsBarbara Geric, Stuart Johnson, Dale N Gerding, et al.Nature|March 3, 2009
Toxin B is essential for virulence of Clostridium difficileDena Lyras, Jennifer R O'Connor, Pauline M Howarth, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2007
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximinStuart Johnson, Christopher Schriever, Minerva Galang, et al.Journal of Clinical Microbiology|February 27, 2015
Differential immunodetection of toxin B from highly virulent Clostridium difficile BI/NAP-1/027Nira R Pollock, Linan Song, Mingwei Zhao, et al.Pageof 24